SEC Form 4 · accession 0001645627-18-000025
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 7, 2018
Accepted (ET)
May 10, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2018 | P | 500 | $0.034 | A | 25,015,789 | D | |
| Common Stock | May 7, 2018 | P | 500 | $0.034 | A | 25,016,289 | D | |
| Common Stock | May 7, 2018 | P | 1,000 | $0.0345 | A | 25,017,289 | D | |
| Common Stock | May 7, 2018 | P | 1,000 | $0.0329 | A | 25,018,289 | D | |
| Common Stock | May 8, 2018 | P | 1,000 | $0.0345 | A | 25,019,289 | D | |
| Common Stock | May 8, 2018 | P | 1,000 | $0.0345 | A | 25,020,289 | D | |
| Common Stock | May 8, 2018 | P | 1,000 | $0.0344 | A | 25,021,289 | D | |
| Common Stock | May 8, 2018 | P | 100 | $0.0344 | A | 25,021,389 | D | |
| Common Stock | May 8, 2018 | P | 1,000 | $0.0344 | A | 25,022,389 | D |
Table II — derivative securities
No Table II lines on this filing.